ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionAmalgamated Bank
Latest Disclosed Ownership36,020 shares
Latest Disclosed Value $ 802
Amalgamated Bank reports 0.67% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 8, 2026 - Amalgamated Bank filed a 13F-HR form disclosing ownership of 36,020 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $802 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 36,262 shares of ACADIA Pharmaceuticals Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 36,020 -242 -0.67 1 0.0061
2026-02-05 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 36,262 -48 -0.13 1 0.0070
2025-10-29 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 36,310 1,219 3.47 1 0.0055
2025-08-04 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 35,091 89 0.25 1 0.0058
2025-04-25 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 35,002 30,921 757.68 1 0.0050
2025-02-04 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,081 -224 -5.20 0 0.0006
2024-10-30 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,305 0 0.00 0 0.0005
2024-08-12 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 4,305 190 4.62 0 0.0006
2024-04-23 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 4,115 -13,346 -76.43 0 0.0006
2024-02-06 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 17,461 -1,224 -6.55 1 0.0044
2023-11-08 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,685 276 1.50 0 0.0033
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,409 1,367 8.02 0 0.0036
2023-05-02 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 17,042 -2,838 -14.28 0 0.0027
2023-02-10 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 19,880 622 3.23 0 -100.00 0.0028
2022-11-09 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 19,258 307 1.62 315 17.98 0.0030
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,951 -642 -3.28 267 -43.79 0.0025
2022-08-25 2022-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 19,593 -1,471 -6.98 475 -3.46 0.0037
2022-06-30 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 19,593 -1,471 475 0.0038
2022-02-15 2021-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 21,064 -311 -1.45 492 38.59 0.0036
2022-02-15 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,064 -311 492 0.0036
2021-10-29 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 21,375 -1,228 -5.43 355 -35.57 0.0030
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,603 2,018 9.80 551 3.77 0.0044
2021-05-13 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,585 -1,795 -8.02 531 -55.60 0.0199
2021-02-12 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 22,380 -1 -0.00 1,196 29.58 0.0453
2020-10-30 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,381 -295 -1.30 923 -16.01 0.0401
2020-08-10 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 22,676 2,562 12.74 1,099 29.29 0.0509
2020-05-13 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,114 -661 -3.18 850 -4.39 0.0208
2020-02-13 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 20,775 2,067 11.05 889 32.10 0.0164
2019-11-13 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,708 -219 -1.16 673 33.00 0.0142
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,927 1,665 9.65 506 9.29 0.0118
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 17,262 2,918 20.34 463 99.57 0.0112
2019-02-15 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 14,344 14,344 232 0.0066
2018-11-14 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -15,055 -100.00 0 -100.00
2018-07-18 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 15,055 -5,966 -28.38 230 -51.27 0.0056
2018-05-22 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 21,021 1,338 6.80 472 -20.40 0.0125
2018-02-13 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 19,683 1,410 7.72 593 -13.81 0.0160
2017-11-09 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 18,273 392 2.19 688 37.88 0.0214
2017-08-10 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 17,881 3,912 28.00 499 3.96 0.0164
2017-05-12 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 13,969 -3,076 -18.05 480 -2.44 0.0239
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 17,045 2,153 14.46 492 3.80 0.0222
2016-11-15 2016-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 14,892 458 3.17 474 3.04 0.0275
2016-08-16 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 14,434 5,565 62.75 460 85.48 0.0266
2016-05-11 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 8,869 1,200 15.65 248 -9.16 0.0242
2016-02-10 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,669 -686 -8.21 273 -1.09 0.0337
2015-11-04 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 8,355 112 1.36 276 -20.00 0.0290
2015-07-10 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 8,243 766 10.24 345 41.39 0.0339
2015-04-22 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,477 7,477 244 0.0298
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.